Caspase-2 cleavage of tau reversibly impairs memory (original) (raw)

• Spillantini, M.G. & Goedert, M. Tau pathology and neurodegeneration. Lancet Neurol. 12, 609–622 (2013).
  CAS PubMed Google Scholar
• Ballatore, C., Lee, V.M. & Trojanowski, J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663–672 (2007).
  CAS PubMed Google Scholar
• Ittner, L.M. et al. Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models. Cell 142, 387–397 (2010).
  CAS PubMed Google Scholar
• Yamada, K. et al. Neuronal activity regulates extracellular tau in vivo. J. Exp. Med. 211, 387–393 (2014).
  CAS PubMed PubMed Central Google Scholar
• Dixit, R., Ross, J.L., Goldman, Y.E. & Holzbaur, E.L. Differential regulation of dynein and kinesin motor proteins by tau. Science 319, 1086–1089 (2008).
  CAS PubMed PubMed Central Google Scholar
• Fath, T., Eidenmüller, J. & Brandt, R. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J. Neurosci. 22, 9733–9741 (2002).
  CAS PubMed PubMed Central Google Scholar
• de Calignon, A. et al. Caspase activation precedes and leads to tangles. Nature 464, 1201–1204 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gomez-Isla, T. et al. Clinical and pathological correlates of apolipoprotein E–ɛ4 in Alzheimer's disease. Ann. Neurol. 39, 62–70 (1996).
  CAS PubMed Google Scholar
• Rocher, A.B. et al. Structural and functional changes in tau-mutant mice neurons are not linked to the presence of NFTs. Exp. Neurol. 223, 385–393 (2010).
  CAS PubMed Google Scholar
• Menkes-Caspi, N. et al. Pathological tau disrupts ongoing network activity. Neuron 85, 959–966 (2015).
  CAS PubMed Google Scholar
• Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476–481 (2005).
  CAS PubMed PubMed Central Google Scholar
• Ramsden, M. et al. Age-dependent neurofibrillary tangle formation, neuron loss and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 25, 10637–10647 (2005).
  CAS PubMed PubMed Central Google Scholar
• Kopeikina, K.J. et al. Synaptic alterations in the rTg4510 mouse model of tauopathy. J. Comp. Neurol. 521, 1334–1353 (2013).
  CAS PubMed PubMed Central Google Scholar
• Rawlings, N.D., Waller, M., Barrett, A.J. & Bateman, A. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 42, D503–D509 (2014).
  CAS PubMed Google Scholar
• Hoover, B.R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067–1081 (2010).
  CAS PubMed PubMed Central Google Scholar
• Zempel, H., Thies, E., Mandelkow, E. & Mandelkow, E.M. Aβ oligomers cause localized Ca2+ elevation, missorting of endogenous tau into dendrites, tau phosphorylation and destruction of microtubules and spines. J. Neurosci. 30, 11938–11950 (2010).
  CAS PubMed PubMed Central Google Scholar
• Miller, E.C. et al. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits. Eur. J. Neurosci. 39, 1214–1224 (2014).
  PubMed PubMed Central Google Scholar
• Fasulo, L. et al. The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J. Neurochem. 75, 624–633 (2000).
  CAS PubMed Google Scholar
• Cotman, C.W., Poon, W.W., Rissman, R.A. & Blurton-Jones, M. The role of caspase cleavage of tau in Alzheimer disease neuropathology. J. Neuropathol. Exp. Neurol. 64, 104–112 (2005).
  CAS PubMed Google Scholar
• Bergeron, L. et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12, 1304–1314 (1998).
  CAS PubMed PubMed Central Google Scholar
• Isaac, J.T., Nicoll, R.A. & Malenka, R.C. Evidence for silent synapses: implications for the expression of LTP. Neuron 15, 427–434 (1995).
  CAS PubMed Google Scholar
• Liao, D., Hessler, N.A. & Malinow, R. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature 375, 400–404 (1995).
  CAS PubMed Google Scholar
• Shalini, S., Dorstyn, L., Dawar, S. & Kumar, S. Old, new and emerging functions of caspases. Cell Death Differ. 22, 526–539 (2015).
  CAS PubMed Google Scholar
• Kumar, S., Kinoshita, M., Noda, M., Copeland, N.G. & Jenkins, N.A. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1β-converting enzyme. Genes Dev. 8, 1613–1626 (1994).
  CAS PubMed Google Scholar
• Tiwari, M. et al. A non-apoptotic role for CASP2/caspase-2: modulation of autophagy. Autophagy 10, 1054–1070 (2014).
  CAS PubMed PubMed Central Google Scholar
• Shalini, S. et al. Caspase-2 protects against oxidative stress in vivo. Oncogene 34, 4995–5002 (2015).
  CAS PubMed Google Scholar
• Upton, J.P. et al. IRE-1α cleaves select microRNAs during ER stress to de-repress translation of pro-apoptotic caspase-2. Science 338, 818–822 (2012).
  CAS PubMed PubMed Central Google Scholar
• Pozueta, J. et al. Caspase-2 is required for dendritic spine and behavioral alterations in J20 APP transgenic mice. Nat. Commun. 4, 1939 (2013).
  PubMed PubMed Central Google Scholar
• Carroll, J.B. et al. Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease. Mol. Neurodegener. 6, 59 (2011).
  PubMed PubMed Central Google Scholar
• Lee, S. & Shea, T.B. Caspase-mediated truncation of tau potentiates aggregation. Int. J. Alzheimers Dis. 2012, 731063 (2012).
  PubMed PubMed Central Google Scholar
• Wang, Y., Garg, S., Mandelkow, E.M. & Mandelkow, E. Proteolytic processing of tau. Biochem. Soc. Trans. 38, 955–961 (2010).
  CAS PubMed Google Scholar
• Dolan, P.J. & Johnson, G.V. A caspase-cleaved form of tau is preferentially degraded through the autophagy pathway. J. Biol. Chem. 285, 21978–21987 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gamblin, T.C. et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 100, 10032–10037 (2003).
  CAS PubMed Google Scholar
• Spires-Jones, T.L., Stoothoff, W.H., de Calignon, A., Jones, P.B. & Hyman, B.T. Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci. 32, 150–159 (2009).
  CAS PubMed Google Scholar
• Zhang, Z. et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease. Nat. Med. 20, 1254–1262 (2014).
  CAS PubMed PubMed Central Google Scholar
• Abraha, A. et al. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J. Cell Sci. 113, 3737–3745 (2000).
  CAS PubMed Google Scholar
• Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337–351 (2007).
  CAS PubMed Google Scholar
• Davies, P. Characterization and use of monoclonal antibodies to tau and paired-helical-filament tau. Methods Mol. Med. 32, 361–373 (2000).
  CAS PubMed Google Scholar
• Hunsberger, H.C. et al. Effect size of memory deficits in mice with adult-onset P301L tau expression. Behav. Brain Res. 272, 181–195 (2014).
  CAS PubMed PubMed Central Google Scholar
• Westerman, M.A. et al. The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22, 1858–1867 (2002).
  CAS PubMed PubMed Central Google Scholar
• Wolfer, D.P., Madani, R., Valenti, P. & Lipp, H.P. Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol. Behav. 73, 745–753 (2001).
  CAS PubMed Google Scholar
• Lesné, S. et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352–357 (2006).
  PubMed Google Scholar
• Wang, X. et al. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. Nat. Med. 19, 473–480 (2013).
  CAS PubMed PubMed Central Google Scholar